ScholarGate
المساعد

قارن الطرق

راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.

جودة الحياة في سرطان الرئة: EORTC QLQ-LC13×مقياس القلق من السرطان: قياس الضائقة النفسية في رعاية مرضى السرطان×
المجالعلم الأورامعلم الأورام
العائلةProcess / pipelineProcess / pipeline
سنة النشأة19941991
صاحب الطريقةBergman, B., et al. (EORTC Quality of Life Group)Lerman, C., et al.
النوعSelf-report questionnaireSelf-report questionnaire
المصدر التأسيسيBergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(1), 259–267. DOI ↗
الأسماء البديلةQLQ-LC13CWS
ذات صلة55
الملخصThe EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional impairment. It is widely used in cancer screening, treatment, and survivorship contexts to identify patients requiring psychological support.
ScholarGateمجموعة البيانات
  1. v1
  2. 2 المصادر
  3. PUBLISHED
  1. v1
  2. 1 المصادر
  3. PUBLISHED

انتقل إلى البحث تنزيل الشرائح

ScholarGateقارن الطرق: EORTC QLQ-LC13 · Cancer Worry Scale. استُرجع بتاريخ 2026-06-19 من https://scholargate.app/ar/compare